Speciality: All Speciality
Description:
A warm welcome to all the medical professionals in this interesting session on The game changing DTP Combination Vaccine evolution to improve VCR.
The DTP (Diphtheria, Tetanus, and Pertussis) combination vaccine has been a cornerstone of childhood immunization programs worldwide. Its evolution marks significant advancements in improving vaccine coverage rates (VCR), ensuring broader protection against these serious infectious diseases.
Over the years, the DTP vaccine has undergone several modifications to enhance its efficacy and safety. Initially, whole-cell pertussis vaccines were used, which, although effective, were associated with higher rates of adverse reactions. The development of acellular pertussis vaccines (DTaP) offered a safer alternative with fewer side effects, leading to increased acceptance and higher vaccination rates.
Research is being conducted to develop next-generation vaccines that offer even broader protection with fewer doses. Additionally, efforts to educate communities and address vaccine hesitancy are essential to further improve VCR and sustain the gains achieved in controlling these preventable diseases.
Therefore, get an overall knowledge of the game changing DTP combination vaccine evolution to improve VCR.
See More Webinars @ Hidoc Webinars
1.
Why preventive mastectomy isn't offered to everyone at risk
2.
Financial hardship common in patients with cancer
3.
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.
4.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
5.
Severe obesity associated with reduced prevalence of recommended cancer screenings
1.
Sound Waves and Self-Destruction: A Promising Nanotech Weapon in the Fight Against Cancer
2.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
3.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
4.
Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells
5.
Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
3.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation